Therapeutic efficacy of compound Xuanju capsule on type III prostatitis.
- Author:
Guang-Ping PENG
1
;
De-Zhu QI
;
Ke-Qing HU
;
Zeng-Yi LIU
;
Pei-Geng WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Drugs, Chinese Herbal; therapeutic use; Humans; Male; Middle Aged; Phytotherapy; Prostatitis; drug therapy; Treatment Outcome; Young Adult
- From: National Journal of Andrology 2013;19(6):551-554
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the therapeutic effect of Compound Xuanju Capsule on type III prostatitis.
METHODSA total of 242 patients with type III prostatitis diagnosed by the NIH criteria were randomly divided into an experimental and a control group of equal number, the former treated with Compound Xuanju Capsule + Tamsulosin Hydrochloride, and the latter with Quinolinone antibiotics + Tamsulosin and Hydrochloride, both for 6 months. After treatment, we assessed the therapeutic effects based on the NIH-CPSI scores and the improvement of relevant complications.
RESULTSAll the 242 patients completed the treatment. The total effectiveness rate was 77.69% (94/121) in the experimental group, 71.56% (78/109) in those with complications. In comparison, it was only 47.10% (57/121) in the control group, 31.78% (34/107) in those with complications. Both the NIH-CPSI scores and the improvement of complications were significantly higher in the experimental than in the control group (P < 0.05).
CONCLUSIONCompound Xuanju Capsule has a good therapeutic effect on type III prostatitis.
